Skip to content
777 Sourcing.

Capability

epigenetic drug design

Suppliers
1
States & provinces
1
Countries
1

1 epigenetic drug design supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

EPIGENETIX, INC.

DELRAY BEACH, FL

Epigenetix Inc. designs epigenetic drugs; its first drug, EP31670 (NEO2734), is a first-in-class oral once daily dual BRD4 and p300/CBP inhibitor in clinical trials (late stage 1) focused on myelofibrosis and other cancers. Clinical trials are ongoing at the University of Miami (Sylvester), MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, and the University of Washington/Fred Hutchinson Cancer Research Center.

clinical developmentdrug discovery

Compiled from public sources

Related capabilities

Other processes offered by the shops that list epigenetic drug design.

Browse all capabilities